Publications

• Access to gene therapy for sickle cell disease in Africa.
  EBioMedicine Volume: 115 Page(s): 105713
  05/01/2025 Authors: Makani J; Bukini D; Malangahe S; Arnold SD; Patel S; Rifai A; Moshi G
• Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.
  Br J Haematol Volume: 206 Page(s): 368 - 371
  01/01/2025 Authors: Frost EL; Chonat S; Williams KM; Aumann W; Stevenson J; Yin J; Schniederjan M; Arnold S; Schoettler ML
• Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis.
  Am J Hematol Volume: 99 Page(s): 2037 - 2040
  10/01/2024 Authors: Arnold SD; Bakshi N; Ross D; Smith C; Sinha C; Veludhandi A; Dutreuil V; Bai S; Meacham LR; Guilcher G
• Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 30 Page(s): 912.e1 - 912.e13
  09/01/2024 Authors: George SA; Veludhandi A; Xiang Y; Liu K; Stenger E; Arnold SD; Mehta A; Schirmer DA; Spencer JB; Guilcher GMT
• Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities.
  Blood Adv Volume: 8 Page(s): 3497 - 3506
  07/09/2024 Authors: Khera N; Ailawadhi S; Brazauskas R; Patel J; Jacobs B; Ustun C; Ballen K; Abid MB; Diaz Perez MA; Al-Homsi AS
• Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.
  Cancer Med Volume: 13 Page(s): e6966
  04/01/2024 Authors: Newman H; Li Y; Huang Y-SV; Elgarten CW; Myers RM; Ruiz J; Zheng DJ; Leahy AB; Aftandilian C; Arnold SD
• Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.
  Ann Intern Med Volume: 177 Page(s): 155 - 164
  02/01/2024 Authors: Basu A; Winn AN; Johnson KM; Jiao B; Devine B; Hankins JS; Arnold SD; Bender MA; Ramsey SD
• Identifying and Preventing Disparities in Access to Curative Therapy for SCD.
  Transplant Cell Ther Volume: 30 Page(s): 9 - 10
  01/01/2024 Authors: Arnold SD
• Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 Pandemic.
  Pediatrics Volume: 152
  11/01/2023 Authors: Molloy MJ; Auger KA; Hall M; Shah SS; Schondelmeyer AC; Parikh K; Kazmier KM; Katragadda H; Jacob SA; Jerardi KE
• Racial and Socioeconomic Disparities in Long-Term Outcomes in 1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis.
  Transplant Cell Ther Volume: 29 Page(s): 709.e1 - 709.e11
  11/01/2023 Authors: Blue BJ; Brazauskas R; Chen K; Patel J; Zeidan AM; Steinberg A; Ballen K; Kwok J; Rotz SJ; Perez MAD
• Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemia.
  Pediatr Blood Cancer Volume: 70 Page(s): e30420
  08/01/2023 Authors: Szymczak JE; Getz KD; Madding R; Shuster S; Aftandilian C; Arnold SD; Collier AB; Gramatges MM; Henry M; Hijiya N
• Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?
  Transplant Cell Ther Volume: 29 Page(s): 531.e1 - 531.e4
  08/01/2023 Authors: Meacham LR; George S; Veludhandi A; Pruett MC; Haight AE; Arnold SD; Elchuri S; Stenger E; Krishnamurti L
• CLINICAL OUTCOMES OF CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
  Volume: 70 Page(s): S134 - S135
  06/01/2023 Authors: Saleem N; Graciaa S; McElfresh P; Arnold S; Schoettler M; Briones M; Chonat S
• Identifying and Validating Pediatric Hospitalizations for MIS-C Through Administrative Data.
  Pediatrics Volume: 151
  05/01/2023 Authors: Auger KA; Hall M; Arnold SD; Bhumbra S; Bryan MA; Hartley D; Ivancie R; Katragadda H; Kazmier K; Jacob SA
• Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia.
  Infect Control Hosp Epidemiol Volume: 44 Page(s): 222 - 229
  02/01/2023 Authors: Elgarten CW; Otto WR; Shenton L; Stein MT; Horowitz J; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB
• Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.
  Transplant Cell Ther Volume: 29 Page(s): 47.e1 - 47.e10
  01/01/2023 Authors: Stenger E; Xiang Y; Wetzel M; Gillespie S; Chellapandian D; Shah R; Arnold SD; Bhatia M; Chaudhury S; Eckrich MJ
• Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase IV Syndrome.
  J Pediatr Hematol Oncol Volume: 45 Page(s): e139 - e141
  01/01/2023 Authors: Fridlyand DM; Chandrakasan S; Aljudi A; Aumann WK; Westfall E; Kirwan B; Bryson EW; Keller FG; Arnold SD; Hong AL
• Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.
  JMIR Res Protoc Volume: 11 Page(s): e36780
  07/06/2022 Authors: Krishnamurti L; Arnold SD; Haight A; Abraham A; Guilcher GM; John T; Bakshi N; Shenoy S; Syrjala K; Martin PL
• Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
  Blood Adv Volume: 6 Page(s): 3058 - 3061
  05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
• Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
  JAMA Netw Open Volume: 4 Page(s): e2128385
  10/01/2021 Authors: Getz KD; Szymczak JE; Li Y; Madding R; Huang Y-SV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB
• Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease.
  Transplant Cell Ther Volume: 27 Page(s): 685.e1 - 685.e8
  08/01/2021 Authors: Mupfudze TG; Meyer C; Preussler JM; Mau L-W; Bolon Y-T; Steinert P; Arnold SD; Saber W; Krishnamurti L
• HSCT RESCUES MARROW FAILURE IN A PATIENT WITH LEUKEMIA AND PREVIOUSLY UNDIAGNOSED LIGASE IV SYNDROME
  Volume: 68 Page(s): S184 - S185
  06/01/2021 Authors: Fridlyand D; Chandrakasan S; Aljudi A; Aumann W; Westfall E; Kirwan B; Bryson E; Keller F; Arnold S; Hong A
• HSCT RESCUES MARROW FAILURE IN A PATIENT WITH LEUKEMIA AND PREVIOUSLY UNDIAGNOSED LIGASE IV SYNDROME
  Volume: 68 Page(s): S198 - S199
  06/01/2021 Authors: Fridlyand DM; Chandrakasan S; Aljudi A; Aumann W; Westfall E; Kirwan B; Bryson EW; Keller FG; Arnold SD; Hong AL
• A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD).
  Volume: 27 Page(s): 345 - 351
  04/01/2021 Authors: Mupfudze TG; Preussler JM; Sees JA; SanCartier M; Arnold SD; Devine S
• Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
  Blood Volume: 137 Page(s): 556 - 568
  01/28/2021 Authors: Bona K; Brazauskas R; He N; Lehmann L; Abdel-Azim H; Ahmed IA; Al-Homsi AS; Aljurf M; Arnold SD; Badawy SM
• Developing a validated patient-reported outcome instrument to assess financial hardship among hematopoietic cell transplant recipients for sickle cell disease
  Volume: 29 Page(s): S79 - S79
  10/01/2020 Authors: Arnold S; Ross D; Sinha C; Smith C; Krishnamurti L
• The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis.
  Biol Blood Marrow Transplant Volume: 26 Page(s): 1747 - 1756
  09/01/2020 Authors: Arnold SD; Brazauskas R; He N; Li Y; Hall M; Atsuta Y; Dalal J; Hahn T; Khera N; Bonfim C
• Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.
  Biol Blood Marrow Transplant Volume: 26 Page(s): 333 - 342
  02/01/2020 Authors: Zinter MS; Logan BR; Fretham C; Sapru A; Abraham A; Aljurf MD; Arnold SD; Artz A; Auletta JJ; Chhabra S
• Pediatric Intensive Care Resource Utilization Following Hematopoietic Cell Transplantation in Children with Acute Leukemia
  Volume: 134
  11/13/2019 Authors: Baldes C; Wetzel M; McCracken C; Saber W; Arnold SD
• Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children.
  Pediatrics Volume: 144
  07/01/2019 Authors: Brousseau DC; Richardson T; Hall M; Ellison AM; Shah SS; Raphael JL; Bundy DG; Arnold S
• Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation.
  Infect Control Hosp Epidemiol Volume: 39 Page(s): 797 - 805
  07/01/2018 Authors: Elgarten CW; Arnold SD; Li Y; Huang Y-SV; Riches ML; Gerber JS; Aplenc R; Saber W; Fisher BT
• Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation.
  Biol Blood Marrow Transplant Volume: 24 Page(s): 1111 - 1118
  06/01/2018 Authors: Burns LJ; Abbetti B; Arnold SD; Bender J; Doughtie S; El-Jawahiri A; Gee G; Hahn T; Horowitz MM; Johnson S
• Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemia.
  Pediatr Blood Cancer Volume: 65
  04/01/2018 Authors: Szymczak JE; Getz KD; Madding R; Fisher B; Raetz E; Hijiya N; Gramatges MM; Henry M; Mian A; Arnold SD
• Improved Mortality Prognostication for Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results From a Virtual Pediatric Systems (VPS) and Center for International Blood and Marrow Transplant Research (CIBMTR) Database Merger
  Volume: 24 Page(s): S98 - S100
  03/01/2018 Authors: Zinter MS; Logan BR; Zhu X; Sapru A; Abraham A; Aljurf MD; Arnold SD; Artz A; Auletta JJ; Chhabra S
• Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome.
  JAMA Pediatr Volume: 171 Page(s): 1090 - 1099
  11/01/2017 Authors: Bundy DG; Richardson TE; Hall M; Raphael JL; Brousseau DC; Arnold SD; Kalpatthi RV; Ellison AM; Oyeku SO; Shah SS
• Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.
  Haematologica Volume: 102 Page(s): 1823 - 1832
  11/01/2017 Authors: Arnold SD; Brazauskas R; He N; Li Y; Aplenc R; Jin Z; Hall M; Atsuta Y; Dalal J; Hahn T
• Timing and Utility of Relapse Surveillance after Allogeneic Hematopoietic Cell Transplantation in Children with Leukemia.
  Biol Blood Marrow Transplant Volume: 23 Page(s): 696 - 700
  04/01/2017 Authors: Levinson A; Arnold S; Jin Z; Bhatia M; George D; Garvin JH; Satwani P
• Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
  Biol Blood Marrow Transplant Volume: 23 Page(s): 552 - 561
  04/01/2017 Authors: Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J
• Role of Donor Source on Clinical Outcomes and Inpatient Resource Utilization for Hematopoietic Cell Transplantation in Children with Acute Leukemia
  Volume: 128
  12/02/2016 Authors: Arnold SD; Brazauskas R; He N; Li Y; Satwani P; Pulsipher MA; Hall M; Atsuta Y; Dalal JD; Hahn T
• Reply to: Using Appropriate Methods in Cost-Effectiveness Analyses: The Case of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease.
  Biol Blood Marrow Transplant Volume: 22 Page(s): 2110 - 2111
  11/01/2016 Authors: Arnold SD
• Imaging findings in a child with calcineurin inhibitor-induced pain syndrome after bone marrow transplant for beta thalassemia major.
  Pediatr Radiol Volume: 46 Page(s): 1618 - 1621
  10/01/2016 Authors: Ayyala RS; Arnold SD; Bhatia M; Dastgir J
• Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation.
  Biol Blood Marrow Transplant Volume: 22 Page(s): 1646 - 1653
  09/01/2016 Authors: Rustia E; Violago L; Jin Z; Foca MD; Kahn JM; Arnold S; Sosna J; Bhatia M; Kung AL; George D
• Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.
  Br J Haematol Volume: 174 Page(s): 515 - 525
  08/01/2016 Authors: Arnold SD; Bhatia M; Horan J; Krishnamurti L
• A Study of Predictors of Clinical Outcomes and Healthcare Utilization in Children with Sickle Cell Disease Undergoing Allogeneic Hematopoietic Cell Transplantation
  Volume: 126
  12/03/2015 Authors: Satwani P; Brazauskas R; Arnold SD; He N; Li Y; Aplenc R; Hall M; Atsuta Y; Dalal JD; Hahn T
• Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.
  Pediatr Blood Cancer Volume: 62 Page(s): 1775 - 1781
  10/01/2015 Authors: Getz KD; Li Y; Alonzo TA; Hall M; Gerbing RB; Sung L; Huang Y-S; Arnold S; Seif AE; Miller TP
• Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center Analysis.
  Biol Blood Marrow Transplant Volume: 21 Page(s): 1258 - 1265
  07/01/2015 Authors: Arnold SD; Jin Z; Sands S; Bhatia M; Kung AL; Satwani P
• Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
  Volume: 21 Page(s): S231 - S232
  02/01/2015 Authors: Levinson A; Arnold S; Kung A; Bhatia M; George D; Garvin J; Satwani P
• Standardized costs and outcome in children treated with gemtuzumab on the AAML0531 trial: A report from the Children's Oncology Group.
  Volume: 32
  05/20/2014 Authors: Aplenc R; Fisher B; Li Y; Alonzo TA; Gerbing RB; Hall M; Arnold SD; Huang Y-S; Seif AE; Bagatell R
• Allogeneic Stem Cell Transplantation for Children with Sickle Cell Disease Achieves Quality of Life Similar to Normal Children and Is Cost Effective
  Volume: 20 Page(s): S79 - S79
  02/01/2014 Authors: Arnold S; Jin Z; Weinberg A; Bishop J; Sands S; Licursi M; Bhatia M; Kung A; Satwani P
• Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
  Br J Haematol Volume: 156 Page(s): 730 - 743
  03/01/2012 Authors: Miles RR; Arnold S; Cairo MS
• Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors.
  Neuro Oncol Volume: 10 Page(s): 171 - 181
  04/01/2008 Authors: Arnold SD; Forman LM; Brigidi BD; Carter KE; Schweitzer HA; Quinn HE; Guill AB; Herndon JE; Raynor RH